Biopesticides Market - Strategic Insights and Forecasts (2026-2031)

The Biopesticides Market is projected to grow at a CAGR of 9.03%, reaching USD 16.1 billion in 2031 from USD 10.5 billion in 2026.

Report Overview

Biopesticides comprise commercially supplied crop-protection formulations whose pesticidal action arises from microorganisms, naturally occurring substances, fermentation-derived compounds or other eligible biological mechanisms. The market includes bio-insecticides, bio nematicides, bio-herbicides, bio-fungicides and complementary products sold for foliar, soil, seed and post-harvest use. Microbial and biochemical inputs are counted when marketed as pesticides; fertilizers, stand-alone biostimulants, beneficial insects sold solely as live predators and pesticidal traits embodied in seed prices are not included in formulated-product sales.

Manufacturers span microbial-fermentation specialists, botanical-extract producers and diversified agricultural-input groups. BASF markets its Serifel microbial fungicide, Bayer supplies Serenade biological fungicides, Certis Biologicals operates fermentation and botanical extraction facilities, and Koppert supplies microbial crop-protection products alongside other biocontrol tools. Sales reflect registered formulations and actual deployment rather than laboratory strains or uncommercialized research. Product specifications, approved uses and local distribution remain important determinants of revenue.

Market Overview

Microbial crop-protection products operate through several mechanisms: some Bacillus strains interfere with pathogen colonization, fungal agents can suppress insect pests, and specific baculoviruses target susceptible larvae. Biochemical approaches include mating disruption and botanically sourced pesticidal compounds. These mechanisms affect dosage, treatment windows and the compatibility of biologicals with conventional programmes. United States EPA guidance separates microbial and biochemical pesticides from plant-incorporated protectants; commercial formulation sales should not be confused with the value of seed containing pesticidal traits.

Recent supplier investment is concentrating on repeatable production and easier adoption. BASF commissioned a fermentation facility in Ludwigshafen in May 2026 to manufacture biological crop-protection inputs, including material associated with its Serifel portfolio. Koppert's September 2026 launch of Macan in Brazil brought a Bacillus velezensis foliar fungicide into soybean, corn and sugarcane disease programmes. Such products require field-specific performance proof as well as reliable storage and tank-mix behaviour.

Growers assess a biological input according to disease or pest control, yield protection and operational disruption. In high-value vegetables, additional spray costs may be justified by export-residue limits or short harvest intervals; broad-acre growers place greater emphasis on per-hectare cost, application logistics and the consistency of results across variable weather. Multiple agronomic channels coexist, from specialist biological distributors to multinational crop-protection suppliers adding biologicals to integrated pest-management recommendations.

Market Trends

• Microbial Fungicides Are Entering Broad-Acre Spray Programmes

Microbial fungicides are increasingly designed for use outside protected horticulture, where operators need compatibility with established sprayers and treatment schedules. Koppert's Macan, launched in Brazil in September 2026, is registered against foliar disease targets in soybean, corn and sugarcane. Its Bacillus velezensis formulation illustrates the shift from niche greenhouse crops toward large-area disease-management programmes requiring stable biological activity under field conditions.

Commercial acceptance will depend on how such products perform when combined with fungicide rotations, variable water quality and changing humidity. Growers rarely make purchases on microbial identity alone; label breadth, ease of handling and repeatable suppression across seasons have a stronger bearing on renewal decisions. Suppliers must therefore support on-farm validation as well as manufacturing scale.

• Insect Control Is Diversifying Beyond Conventional Bt

Bacillus thuringiensis remains a widely used platform for controlling susceptible larval insects, but suppliers are introducing additional biological modes of action. Vestaron obtained expanded United States approval in February 2026 for BASIN, a peptide-based insecticide targeting selected lepidopteran and soft-bodied pests. Viral insecticides such as those supplied by Andermatt and AgBiTech offer another targeted route where species-specific control fits established scouting practices.

The technical diversity increases grower options for resistance management without making different biological types interchangeable. Pest identification, larval stage and treatment timing are essential to performance. Suppliers able to specify which pest complexes and application sequences suit each product will be better positioned than companies relying on broad claims about reduced chemical use.

• Production Investment Is Moving Closer to Commercial Demand

BASF's Ludwigshafen BioHub began commercial production of biological crop-protection inputs in 2026. The facility uses fermentation to manufacture active ingredients and improves internal control over batch scheduling and supply. This matters because capacity, contamination control and stable microbial concentrations can determine whether a biological product is available for a narrow crop-treatment window.

Investment in fermentation, extraction and formulation is not a guarantee of market penetration; distribution and registered crop uses remain limiting factors. Nevertheless, suppliers with integrated production can reduce dependence on external manufacturing capacity and adapt production batches to regional demand. The economic benefit is particularly relevant when biological programmes expand from specialty crops into row-crop acreage.

• Natural-Origin Herbicides Are Broadening the Portfolio

Biological pest control has developed more extensively around fungi and insects than around established field-scale weed control. Seipasa's March 2026 launch of Seithor, a natural-origin herbicide authorized in Portugal, shows how manufacturers are extending biological portfolios into a more difficult technical category. Weed-control products must manage variable species, growth stages and field conditions while matching growers' expectations for visible suppression.

Early commercialization is likely to favour specialty crops, targeted applications and programmes that combine several weed-management methods. In row crops, the large treatment area and cost sensitivity raise the threshold for adoption. Bio-herbicide growth should therefore be assessed by actual labeled uses and field economics, rather than treating the existence of a natural active ingredient as evidence of widespread replacement.

Segment Analysis

By Type: Bio-Insecticides

Bio-insecticides remain one of the fastest-developing categories as suppliers supplement established Bt products with viruses, insect-pathogenic fungi and peptide-based formulations. Pest-specific biological action can reduce reliance on repeated treatments from the same chemical mode-of-action group, although success still requires accurate scouting and the right application window. BASF's acquisition of AgBiTech brings baculovirus capabilities into a large crop-protection portfolio, while Vestaron is expanding registered uses for its peptide technology.

The category represents approximately 19.7% of the 2026 market under the reconciled product-revenue boundary. Its proportion increases through 2031 as biological insect-control options reach additional field crops. The broad parent category also includes substantial fungal-disease and weed-control expenditure, so insecticide revenue should not be inferred from a simple share of all biological input spending.

By Crop Type: Fruits and Vegetables

Fruits and vegetables generate a concentrated requirement for preventive biological control because multiple harvests, export specifications and tight pre-harvest intervals complicate chemical spraying. Growers use microbial fungicides for foliage and soil-borne pathogens, botanical insecticides and bio-nematicides to protect crop quality. The sector also contains greenhouse and protected-crop systems where technical advice and repeated applications support relatively high biological product expenditure per hectare.

Sales attributable to this crop group are projected at approximately USD 6.780 billion by 2031. Demand is likely to remain resilient because crop appearance and rejected shipments can have substantial economic consequences. However, the mix differs sharply between berries, leafy vegetables, orchards and protected crops; suppliers need crop-specific labels and efficacy programmes rather than a single generalized horticultural product.

By Application: Foliar Spray

Foliar spraying is the largest application route because insect pests and many fungal pathogens establish on plant foliage, where control depends on coverage and treatment timing. Sprayable microbial and biochemical formulations can enter existing operations without replacing major farm equipment. Syngenta's Taegro and Koppert's Macan illustrate foliar-oriented microbial disease-control options, while targeted insecticides are commonly applied in response to scouting and pest-development stages.

The application channel is expected to account for approximately 48.3% of market value in 2031. Its continued position reflects flexibility across crop systems, although weather-related variability remains an operating challenge. Seed and soil treatments can become more attractive where preventive protection avoids later spray passes, but their efficacy is tied to seed health, establishment conditions and soil biology.

Market Drivers

• Residue Specifications in Fresh Produce

Fruit exporters and retailers face requirements on pesticide residues and the timing of harvest treatments. Biological products can offer useful options where the approved label has a short pre-harvest interval or a suitable residue profile. Bayer's Serenade biological fungicide and several Certis products are designed for disease-management programmes that include high-value produce.

For growers, the business case depends on protecting saleable volume rather than merely reducing chemical applications. Farm managers may combine biological protection near harvest with conventional early-season treatments. This creates repeat purchasing in crops with frequent harvest cycles and stringent quality requirements, while making label conditions and control consistency especially important.

• Broadening Resistance-Management Options

Repeated use of a narrow set of pesticide modes of action increases the need for alternative interventions. Microbial agents, baculoviruses and pesticidal peptides provide additional mechanisms that can be integrated into pest- and disease-management schedules. Vestaron's BASIN and Andermatt's targeted viral insecticides expand the available toolkit for selected insects.

Resistance management does not automatically make every biological product effective in a given field. The pest must be susceptible, exposure adequate and the formulation applied at the correct growth stage. Product suppliers that support monitoring and application guidance can make biologicals part of a defensible rotation plan instead of a separate discretionary purchase.

• Expansion of Organic and Integrated Farming Programmes

FiBL and IFOAM report that the world maintained approximately 99 million hectares of organically managed agricultural land in 2024. Organic production creates recurring demand for permitted protection options, but biological products also serve conventional farms seeking additional tools within integrated pest management. The Organic Trade Association reported United States organic-product sales of USD 76.6 billion in 2025.

Organic acreage is not a direct proxy for biopesticide revenue, since crops, certification rules and input intensity differ substantially. Nevertheless, established demand for organic produce supports suppliers' investment in registrations, advisory services and distribution networks, which can also serve conventional growers.

• Commercial Scale-Up of Biological Manufacturing

Industrial biological production increasingly relies on controlled fermentation and consistent formulation specifications. BASF's May 2026 BioHub commissioning reflects investment in supply assurance for biological active ingredients, while Certis Biologicals operates dedicated facilities for fermentation and botanical extraction. Greater manufacturing control can improve batch repeatability and availability during planting or treatment seasons.

The value of that capacity is realized only when registered products have reliable customer demand. Stronger production networks can reduce delivery risk and improve procurement confidence among large distributors and farm groups, particularly for microbial products whose viability and storage conditions require attention throughout the supply chain.

• Broader Crop and Geography Registrations

A biological active ingredient may have considerable technical potential yet generate little sales where label approval is absent. New geographical registrations extend product portfolios into additional crops and treatment programmes. Certis Biologicals secured the first European authorization for NemaClean in the Netherlands in March 2025, while Koppert introduced its Macan product commercially in Brazil in September 2026.

Registration therefore drives actual sales coverage as much as product discovery. Manufacturers that invest in localized dossiers, trials and technical support can reuse validated biological platforms across markets, although permitted crop uses and environmental requirements must be established jurisdiction by jurisdiction.

Market Restraints

• Uneven Field Efficacy Across Conditions

Microorganisms and biologically derived compounds can be sensitive to ultraviolet light, leaf wetness, temperature or the developmental stage of the target pest. A product that performs well in protected production may behave differently during dry or rainy field conditions. Growers consequently evaluate biologicals against dependable benchmark programmes and may be reluctant to alter critical disease-control schedules.

Reproducible field trials across seasons and agronomic regions are expensive, but essential to overcoming this hesitation. Suppliers need credible performance ranges and precise application recommendations; overly broad claims risk weakening repeat adoption after inconsistent results.

• Formulation Stability and Distribution Requirements

Some microbial formulations require careful control of moisture, temperature and storage duration to maintain viable organisms or active compounds. Heat exposure during distribution, long storage at rural dealers and poor compatibility with tank mixes can reduce delivered performance even when the underlying strain is sound. Viral insecticides and live fungal products also need handling instructions tailored to their biological mechanism.

Shelf-stable spores, improved carriers and simplified packaging reduce these risks but add formulation development and quality-control costs. Expansion into regions with weak cold-chain or warehousing infrastructure may therefore require local production, tighter distributor training or formulations designed for difficult storage conditions.

• Complex and Fragmented Registration Procedures

Biological products face different data requirements across jurisdictions, including microorganism identity, toxicology, environmental effects, manufacturing consistency and crop-specific efficacy. A registration obtained for one crop in one country does not guarantee permission elsewhere. The International Biocontrol Manufacturers Association has documented prolonged approval times for some European biological control products.

Smaller producers must manage multiple dossiers while financing trials and production scale-up before broad commercial sales are possible. Local partnerships can spread the burden, but delays can leave a validated product outside the most attractive seasonal sales windows.

• Application Timing and Grower Training

Target-specific biological treatments often demand earlier intervention than the rescue applications growers associate with some conventional pesticides. Bt products, for example, are usually most effective when susceptible insect larvae are actively feeding and relatively young. Poor pest identification or delayed spraying can make a suitable product appear ineffective.

Distributors and agronomists must explain scouting thresholds, product mixing and treatment intervals. This technical-service burden is manageable in closely advised horticulture but more difficult across dispersed farms with limited extension support. Simple directions and locally proven schedules become meaningful competitive assets.

• Economics of Large-Area Crop Protection

A high-value fruit crop can support frequent biological applications that would be uneconomic on lower-margin commodities. In broad-acre systems, growers compare material price, application passes, logistics and disease-loss avoidance on a per-hectare basis. Biological formulations may need repeated treatments or careful timing, increasing operating cost when pressure is persistent.

New production capacity and higher-concentration formulations can improve cost competitiveness, but price is only part of the decision. A biological input must deliver an acceptable economic return over multiple seasons before it becomes a routine part of large-scale procurement.

Regional Outlook

North America

North America remains the dominant revenue region, representing approximately 34.4% of the global biopesticides market in 2026. The United States combines a large organic-products industry with extensive specialty-crop production and established pesticide-registration procedures. Manufacturers including Certis Biologicals, Sumitomo Biorational and Vestaron serve different parts of this market, from microbial fungicides and Bt platforms to emerging peptide insecticides.

The Organic Trade Association reported USD 76.6 billion in United States organic-product sales during 2025, underscoring the downstream market served by growers managing residue requirements. Canada contributes demand through horticultural and field-crop programmes, while Mexico adds export-oriented fruit and vegetable production. Biological adoption should remain linked to agronomic performance and registration breadth, rather than assuming organic retail spending converts directly into pesticide purchases.

Asia Pacific

Asia Pacific offers the strongest regional growth outlook, with modeled biopesticide revenue reaching approximately USD 4.340 billion by 2031. China and India provide large crop-production bases and increasing local activity in microbial formulations, while Japan and South Korea support higher-value applications where consistent quality, technical support and precise treatment timing matter. Indonesia and Thailand add tropical-crop demand, particularly where disease and insect pressure is persistent.

Regional expansion is not uniform. Smallholder distribution, climate-sensitive storage and country-specific registration can limit adoption even when biologicals demonstrate technical benefits. Locally adapted formulations and accessible advisory networks should matter as much as imported branded products. Wider application in vegetables, fruit crops and selected field crops can gradually increase biological-treatment intensity, provided grower economics remain credible.

Competitive Landscape

Biopesticide competition involves diversified agricultural-input suppliers and specialized biological manufacturers operating on different economic models. BASF and Bayer combine biological crop-protection products with wider chemical and seed offerings, allowing biologicals to be recommended within established grower programmes. Syngenta markets microbial biofungicides and mating-disruption products through its biologicals portfolio. These groups compete on registration coverage, field evidence and distribution reach rather than solely on the number of strains in development.

Certis Biologicals owns fermentation and extraction capabilities and maintains a broad portfolio of microbial and botanical pesticides. Koppert and Andermatt compete through specialized microbial and virus-based products with application support. Sumitomo Biorational, following its 2026 integration of Valent BioSciences, retains an established position in Bt-based insect control, while Vestaron develops peptide-based bioinsecticides. Seipasa has expanded into bioherbicides alongside its biological fungicide and insecticide lines. Product-level differentiation is often more important than company-level scale when a specific pest or disease requires a narrow mechanism.

Consolidation is reshaping parts of the supplier base. BASF completed its acquisition of AgBiTech in March 2026, adding a focused baculovirus platform for insect control. Market success will still depend on local product registration, proven performance and the ability to translate biological technology into reliable field schedules. The manufacturer with the largest distribution network is not necessarily the preferred supplier for every crop or pathogen.

Recent Developments

• 16 September 2026: Koppert launched Macan, a Bacillus velezensis foliar biofungicide, in Brazil for soybean, corn and sugarcane disease-control programmes.

• 11 May 2026: BASF commissioned its BioHub fermentation facility in Ludwigshafen and began commercial production of biological crop-protection inputs, including ingredients associated with Serifel.

• 1 April 2026: BASF announced completion of the AgBiTech acquisition, adding baculovirus-based biological insect-control technologies to its portfolio.

• 31 March 2026: Seipasa introduced its Seithor natural-origin bioherbicide in Portugal following national authorization, extending its registered biocontrol range into weed management.

• 17 February 2026: Vestaron reported United States EPA approval to use its BASIN peptide bioinsecticide on outdoor crops, expanding its previous indoor and greenhouse applications.

• 20 November 2025: BASF announced French registration of Integral Pro microbial fungicide seed treatment for sunflowers, enabling access for the 2026 growing season.

Market Outlook

The next phase of biopesticide commercialization will be shaped by product reliability and market access. Manufacturers with validated strains, robust fermentation controls and practical formulations are positioned to reach growers beyond small organic-production niches. The use of biologicals as complements to established crop-protection chemistry is likely to remain more widespread than wholesale substitution, particularly where pressure from insects and foliar diseases is severe.

New bioherbicides, targeted insecticidal peptides and microbial seed treatments can expand the addressable range of crops and application windows. Adoption will nevertheless vary by region because local approval requirements, formulation storage, distribution capability and grower familiarity affect repeat purchasing. Companies able to demonstrate consistent crop-specific outcomes and establish dependable local supply should capture a greater share of expanding biological crop-protection budgets.

Companies Profiled

• BASF SE

• Bayer AG

• Syngenta AG

• Certis Biologicals

• Koppert B.V.

• Sumitomo Biorational Company LLC

• Andermatt Group AG

• Vestaron Corporation

• Seipasa S.A.

• Bioceres Crop Solutions Corp.

• UPL Limited

• FMC Corporation

Biopesticides Market Scope: